Clinical trials
Infections clinical trials
Below are recruiting infections clinical trials, each written for real people, not researchers. We’re tracking 1,764 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07138144RecruitingPhase 4
Switching to a two-drug HIV pill vs. staying on three drugs
This study tests whether switching to a simpler, two-drug HIV pill (dolutegravir/lamivudine) is as safe and effective as staying on a three-drug regimen. It is for people whose HIV is already well-controlled and who are currently taking Biktarvy or Triumeq.
Mexico City, Mexico CityAges 18–70 - NCT07139366RecruitingPhase 4
Probiotic plus bismuth combo for stubborn H. pylori
This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.
Xi'an, ShaanxiAges 18–75 - NCT07140094Recruiting
Long COVID Relief Through Learning Mindfulness
This study tests whether a mindfulness program can help ease long COVID symptoms. You will learn simple mindfulness techniques and see if they improve your daily life.
New York, New YorkAges 18 years+ - NCT07147517Recruiting
Tracking respiratory viruses in your community and home
This study tracks how respiratory viruses spread in the community and within households. It involves testing and collecting samples from people who are sick or healthy, to help better understand and prevent outbreaks.
La Jolla, CaliforniaAges Any age - NCT07152639RecruitingPhase 3
New skin test for tuberculosis in people 3 and older
This trial tests a new skin test (EEC) to see if it can accurately detect tuberculosis infection in people aged 3 and older. It compares the test's results in healthy people, people with TB, and people with other lung diseases to check how well it works.
Beijing, Beijing MunicipalityAges 3 years+ - NCT07164742Recruiting
Recovery help for lung health after TB treatment
This study tests whether a lung rehabilitation program (like physical therapy for your lungs) can help people who recently started TB treatment breathe and feel better. You need a smartphone and must be willing to attend sessions for 48 weeks.
MangaloreAges 18 years+ - NCT07172451RecruitingPhase 4
Gelaspan vs standard fluids for sepsis with belly infection
This trial tests whether a fluid called Gelaspan (a gelatin-based IV fluid) is better for treating sepsis patients who need emergency abdominal surgery than standard crystalloid fluids. It checks if you have a belly infection and high lactate levels, and you must not have serious heart, lung, or kidney problems.
Guangzhou, GuangdongAges 18 years+ - NCT07179237RecruitingPhase 2
Testing carminal for H. pylori stomach infection
This trial tests a new medicine called carminal for people with stomach inflammation caused by H. pylori bacteria. It aims to see if the drug can help improve symptoms like indigestion and get rid of the infection.
Belgrade, Central SerbiaAges 18 years+ - NCT07184827RecruitingPhase 3
U101 capsules to prevent recurring UTIs in women
This trial tests an oral capsule called U101 to see if it can prevent recurrent urinary tract infections (UTIs) in women who have frequent UTIs. If you've had at least 2 UTIs in the last 6 months or 3 in the last year, you may be able to join.
Kaohsiung CityAges 20–75 - NCT07186244Recruiting
HIV Prevention Study for People Starting or Taking PrEP
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
Chieti, AbruzzoAges 18 years+ - NCT07186465RecruitingPhase 4
Preventing repeat bladder infections in postmenopausal women
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
Bangkok, Phayatai RatchathewiAges 40 years+ - NCT07189936RecruitingPhase 2
Testing 2-HOBA for Immune Issues in Long COVID with POTS
This trial tests if a medication called 2-HOBA can help with ongoing immune system issues in people with Long COVID who also have POTS. It aims to reduce fatigue and other symptoms by calming overactive immune responses.
Nashville, TennesseeAges 18 years+ - NCT07191223Recruiting
Survey on tick-borne encephalitis knowledge for French doctors
This trial asks general practitioners in France to complete a survey about their knowledge of tick-borne encephalitis (a virus spread by ticks that can cause brain swelling). It helps researchers understand how well doctors know about this disease and how to prevent it.
StrasbourgAges 18 years+ - NCT07195032RecruitingPhase 4
MMR vaccine safety in kids after heart transplant
This trial tests whether the MMR (measles, mumps, rubella) vaccine is safe and works well for children who have had a heart transplant. It may help protect you from these diseases if you haven't had the vaccine or no longer have immunity.
Kansas City, MissouriAges 1–17 - NCT07197164RecruitingPhase 2
Remdesivir for kidney transplant patients with mild COVID-19
This trial tests whether giving remdesivir to kidney transplant patients who test positive for COVID-19 can prevent them from getting severely ill. It is for people who have already had at least three COVID-19 vaccine doses and are scheduled to receive a kidney transplant soon.
Badalona, BarcelonaAges 18 years+ - NCT07202052RecruitingPhase 2/Phase 3
Antibiotics or immunoglobulin for infections in blood cancer
This trial compares two treatments—antibiotics or immunoglobulin (a blood product with infection-fighting antibodies)—to see which better prevents infections in people with certain blood cancers like CLL, multiple myeloma, or non-Hodgkin's lymphoma.
Adelaide, South AustraliaAges 18 years+ - NCT07202065RecruitingPhase 2/Phase 3
Preventing infections with antibiotics or immunoglobulin in blood disorders
This study looks at whether a different dose of IVIg (antibody treatment through the vein) or adding antibiotics can help prevent infections in people with low antibody levels. It's for patients already on steady IVIg who cannot safely stop it.
Adelaide, South AustraliaAges 18 years+ - NCT07202078RecruitingPhase 2/Phase 3
Starting immunoglobulin for infection prevention in hematology
This trial tests whether giving immunoglobulin to adults with low antibody levels can prevent infections. It aims to compare immunoglobulin with antibiotic therapy or no added treatment for people with blood conditions.
Adelaide, South AustraliaAges 18 years+ - NCT07202091RecruitingPhase 2/Phase 3
Stopping or extending immunoglobulin therapy to prevent infections
This trial tests whether it is safe to stop or extend immunoglobulin (Ig) therapy for people with low antibody levels, or if switching to preventive antibiotics works just as well to prevent infections.
Adelaide, South AustraliaAges 18 years+ - NCT07203755RecruitingPhase 1
Combination vaccine for whooping cough, Hib, and meningitis
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
Shangqiu, HenanAges 2 months–6 years - NCT07203833Recruiting
Vasorin test for shock diagnosis and outlook
This study looks at a protein called vasorin in the blood to see if it can help diagnose and predict outcomes in people with severe shock in the ICU. It compares patients with septic shock (caused by infection) to those with shock from other causes.
AmiensAges 18 years+ - NCT07204457RecruitingPhase 2/Phase 3
Meningococcal vaccine trial for healthy adults 19 to 55 years old
This trial tests a new meningococcal conjugate vaccine (EG-MCV4) in healthy adults to see how well the body's immune system responds and if it's safe. If you qualify, you'd help researchers learn if this vaccine can prevent meningococcal disease.
SeoulAges 19–55 - NCT07204522Recruiting
Antibiotic therapy for fever with low white blood cells in blood cancer
This trial tests whether an antibiotic called ceftazidime-avibactam (CAZ-AVI) can help patients with blood cancers who have a fever and very low infection-fighting white blood cells. It may be an option for people whose doctors plan to use this specific antibiotic to treat their fever.
Taiyuan, ShanxiAges 18–75 - NCT07211243Recruiting
Comparing two dressings for infected leg ulcers
This trial tests if a new version of a special dressing (Suprasorb X+PHMB Pro) works better than the current version for treating infected venous leg ulcers. It may help people with mildly to moderately draining wounds that are infected.
BialystokAges 18 years+
Hear when a new Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infections?
- Yes. Clin2 currently lists 1,764 recruiting infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.